Upgrade to SI Premium - Free Trial

Candel Therapeutics (CADL)

12.78 -0.19 (1.46%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 1, 2026 4:05 PM - StreetInsider Candel Therapeutics to Present at September Investor Conferences August 26, 2026 8:05 AM - StreetInsider Form 4 Candel Therapeutics, For: Aug 17 Filed by: Tyagarajan Seshu August 19, 2026 4:30 PM - SEC Filing Form 144 Candel Therapeutics, Filed by: Tyagarajan Seshu August 17, 2026 4:37 PM - SEC Filing Candel Therapeutics Inc. (CADL) PT Raised to $15 at Freedom Broker August 17, 2026 12:22 PM - StreetInsider Candel Therapeutics Inc. (CADL) PT Raised to $12 at BofA Securities August 14, 2026 5:18 AM - StreetInsider Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c August 13, 2026 8:58 AM - StreetInsider Form 10-Q Candel Therapeutics, For: Jun 30 August 13, 2026 8:31 AM - SEC Filing Form 8-K Candel Therapeutics, For: Aug 13 August 13, 2026 8:15 AM - SEC Filing Candel Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights August 13, 2026 8:05 AM - StreetInsider Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 3, 2026 4:05 PM - StreetInsider Candel Therapeutics to present prostate cancer data at ASTRO 2026 August 3, 2026 8:05 AM - StreetInsider Candel Therapeutics to Present Extended Data from Phase 3 Results of Aglatimagene Besadenovec at ASTRO 2026 August 3, 2026 8:05 AM - StreetInsider Candel Therapeutics to Present at Canaccord Genuity’s 46th Annual Growth Conference in Boston July 29, 2026 8:05 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Candel Therapeutics Inc. (CADL) July 29, 2026 6:52 AM - StreetInsider Form SCHEDULE 13G Candel Therapeutics, Filed by: BlackRock, Inc. July 27, 2026 4:28 PM - SEC Filing Stifel Starts Candel Therapeutics Inc. (CADL) at Buy July 13, 2026 2:13 AM - StreetInsider Form 4 Candel Therapeutics, For: Jul 06 Filed by: Sims Mark E. July 8, 2026 4:13 PM - SEC Filing Form 3 Candel Therapeutics, For: Jul 06 Filed by: Sims Mark E. July 8, 2026 4:11 PM - SEC Filing Candel Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) July 8, 2026 4:05 PM - StreetInsider Form 4 Candel Therapeutics, For: Jun 29 Filed by: Barone Francesca July 1, 2026 4:23 PM - SEC Filing Form 4 Candel Therapeutics, For: Jun 29 Filed by: Tyagarajan Seshu July 1, 2026 4:22 PM - SEC Filing Form 4 Candel Therapeutics, For: Jun 30 Filed by: Manning Paul B July 1, 2026 4:21 PM - SEC Filing Form 4 Candel Therapeutics, For: Jun 30 Filed by: PAPA JOSEPH C July 1, 2026 4:21 PM - SEC Filing Form 4 Candel Therapeutics, For: Jun 30 Filed by: Loggia Nicoletta July 1, 2026 4:20 PM - SEC Filing Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 1, 2026 4:05 PM - StreetInsider Candel Therapeutics launches phase 3 lung cancer trial for CAN-2409 June 30, 2026 8:05 AM - StreetInsider Candel Therapeutics Announces Initiation of Global Pivotal Phase 3 AURORA Trial Evaluating Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response June 30, 2026 8:05 AM - StreetInsider Form 144 Candel Therapeutics, Filed by: Tyagarajan Seshu June 29, 2026 4:44 PM - SEC Filing Form 144 Candel Therapeutics, Filed by: Barone Francesca June 29, 2026 4:42 PM - SEC Filing Candel Therapeutics names Mark Sims as chief commercial officer June 25, 2026 8:05 AM - StreetInsider Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer June 25, 2026 8:05 AM - StreetInsider Form 4 Candel Therapeutics, For: Jun 23 Filed by: Radhakrishnan Maha June 24, 2026 4:36 PM - SEC Filing Form 4 Candel Therapeutics, For: Jun 23 Filed by: Loggia Nicoletta June 24, 2026 4:35 PM - SEC Filing Form 4 Candel Therapeutics, For: Jun 23 Filed by: PAPA JOSEPH C June 24, 2026 4:34 PM - SEC Filing Form 4 Candel Therapeutics, For: Jun 23 Filed by: Benz Edward J. JR June 24, 2026 4:32 PM - SEC Filing Form 4 Candel Therapeutics, For: Jun 23 Filed by: Martell Christopher June 24, 2026 4:31 PM - SEC Filing Form 4 Candel Therapeutics, For: Jun 23 Filed by: Gaeta Renee June 24, 2026 4:31 PM - SEC Filing Form 4 Candel Therapeutics, For: Jun 23 Filed by: Nabel Gary J. June 24, 2026 4:28 PM - SEC Filing Form 4 Candel Therapeutics, For: Jun 23 Filed by: Nguyen Diem June 24, 2026 4:27 PM - SEC Filing Form 4 Candel Therapeutics, For: Jun 23 Filed by: Manning Paul B June 24, 2026 4:27 PM - SEC Filing Form 8-K Candel Therapeutics, For: Jun 23 June 24, 2026 4:24 PM - SEC Filing Form 8-K Candel Therapeutics, For: Jun 12 June 16, 2026 4:24 PM - SEC Filing Full Article List